Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
antiviral agents
cerebrospinal fluid, elevated protein of
encephalitis
encephalitis, viral
encephalitis, viral-causes of
encephalopathy
immunosuppressive agents
inosiplex
interferon
interferon, intrathecal
interferon, intraventricular
multiple sclerosis
multiple sclerosis, treatment of
Ommaya reservoir
pleocytosis of cerebrospinal fluid
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
treatment of neurologic disorder
viral infection, CNS
Showing articles 0 to 50 of 282 Next >>

Intraventricular Interferon and Oral Inosiplex in the Treatment of Subacute Sclerosing Panencephalitis
Neurol 42:488-491, Yalaz,K.,et al, 1992

Intrathecally Administered Natural Human Fibroblast Interferon Reduces Exacerbations of Multiple Sclerosis
Arch Neurol 44:589-595, Jacobs,L.,et al, 1987

A Major Role for Viruses in Acute Childhood Encephalopathy
Lancet 1:989-991, Kennedy,C.R.,et al, 1986

Multicentre Double-Blind Study of Intrathecally Admin Natural Human Fibroblast Interferon on Exacerb of MS
Lancet 2:1411-1413, Jacobs,L.,et al, 1986

Intrathecal Interferon in the Treatment of Multiple Sclerosis, Patient Follow-Up
Arch Neurol 42:841-847, Jacobs,L.,et al, 1985

Intrathecal Interferon in Multiple Sclerosis
Arch Neurol 39:609-615, Jacobs,L.,et al, 1982

Intrathecal Use Of Interferon In Encephalitis
NEJM 305:1283-1284, Prange,H.,et al, 1981

Spontaneous Intracranial Hypotension Associated with Vascular Malformations
AJNR 46:426-432, Mamlouk,M.D.,et al, 2025

A 64-Year-Old Man with History of Meningitis Presenting with Proximal Weakness of the Arms
Neurol 98:208-213, Karschnia, P.,et al, 2022

An Underrecognized Etiology of New Daily Persistent Headache
Neurol 94:e114-e120, Duvall, J.R.,et al, 2020

Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurol 77:184-191, Luna, G.,et al, 2020

Degenerative Cervical Spondylosis
NEJM 383:159-168, Theodore, N., 2020

Dural Defect Repair as Treatment for Refractory Headache From Cerebrospinal Fluid Leak
Neurol 95:e2831-e2833, Chan,T.L.H., et al, 2020

Neurotoxic Manifestations of High-Dose Intrathecal Gadolinium Administration for CT Myelogram
Radiol Case Reports 15:1992-1995, Malalur, P. & Rajacic, P.C., 2020

Cerebrospinal Fluid Leakage Observed from Skin After Acupuncture
Neurol 92:e1141-e1142, Noh, S.M.,et al, 2019

Intrathecal Administration of Autologous Mesenchymal Stem Cells in Multiple System Atrophy
Neurol 93:e77-e87, Singer, W.,et al, 2019

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 376:221-234,280, Hauser, S.L.,et al, 2017

Acute Spinal Cord Compression
NEJM 376:1358-1369, Ropper, A.E. & Ropper, A.H., 2017

Intrathecal 2-hydroxypropyl-�-cyclodextrin Decreases Neurological Disease Progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial
Lancet 390:1758-1768, Ory, D.S.,et al, 2017

Transient Deficits after Inadvertent Intrathecal Trigger-point Injection with Lidocaine
Neurol 87:848-849, Bereczki, D., et al, 2016

A 52-year-old Man with Diplopia and Ataxia
Neurol 87:e140-e143, Bradshaw, M.J.,et al, 2016

Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016

A 50-year-old Man with Headache and Cognitive Decline
Neurol 85:e182-e186, Batra, A. & Berkowtiz, A., 2015

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015

Disturbances of Cerebrospinal Fluid, Including Hydrocephalus, Pseudotumor Cerebri, and Low-Pressure Syndromes, Intracranial Hypotension
Adams & Victors Principles of Neurology, Chp 30, pg 632, Ropper, A.H.,et al, 2014

The Management of Spasticity in Adults
BMJ 349:g4737, Nair, K.P.S. & Marsden, J., 2014

MR Myelography for Identification of Spinal CSF Leak in Spontaneous Intracranial Hypotension
AJNR 35:2007-2012, Chazen, J.L.,et al, 2014

Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review
JNNP 84:420-426, La Mantia, L.,et al, 2013

Spinal Meningeal Diverticula in Spontaneous Intracranial Hypotension: Analysis of Prevalence and Myelographic Appearance
AJNR 34:1284-1289, Kranz, P.G.,et al, 2013

Primary Leptomeningeal Lymphoma
Neurol 81:1690-1696, Taylor, J.W.,et al, 2013

Sensitivity of MRI of the Spine Compared with CT Myelography in Orthostatic Headache with CSF Leak
Neurol 81:1789-1792, Starling, A.,et al, 2013

Association Between Immediate Initiation of Intramuscular Interferon Beta-1a at the Time of a Clinically Isolated Syndrome and Long-term Outcomes
Arch Neurol 69:183-190, Kinkel,R.P.,et al, 2012

CT Myelography for the Planning and Guidance of Targetetd Epidural Blood Patches in Patients with Persistent Spinal CSF Leakage
AJNR 33:541-544, Wendl,C.M.,et al, 2012

Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012

Cost-effectiveness of disease-modifying therapy for multiple sclerosis
Neurol 77:355-363, Noyes, K.,et al, 2011

Optic Neuritis: Prognosis and Treatment
UpToDate, Jan, Osborne, B.,et al, 2011

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010

Practice Parameter: Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 74:336-343, Delgado,M.R.,et al, 2010

Nosocomial Bacterial Meningitis
NEJM 362:146-154, van de Beek,D.,et al, 2010

Long-Term Survival with Favorable Cognitive Outcome After Chemotherapy in Primary Central Nervous System Lymphoma
Ann Neurol 67:182-189, Juergens,A.,et al, 2010

Pregnancy and Fetal Outcomes After Interferon-b Exposure in Multiple Sclerosis
Neurol 75:1794-1802, Amato,M.P.,et al, 2010

Neuroimaging in Superficial Siderosis: An In-Depth Look
AJNR 31:5-14, Kumar, N., 2010

Aicardi-Gouti�res Syndrome
Br Med Bull 89:183-201, Orcesi, S.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Efficacy of Treatment of MS with IFN B-1b or Glatiramer Acetate by Monthly Brain MRI in the BECOME Study
Neurol 72:1976-1983,1972, Cadavid,D.,et al, 2009

Real-Life Impact of Early Interferon� Therapy in Relapsing Multiple Sclerosis
Ann Neurol 66:513-520, Trojano,M.,et al, 2009

The Present Efficacy of Multiple Sclerosis Therapeutics
Neurol 73:984-990, Klawiter,E.,et al, 2009

Aicardi-Gouti�res Syndrome: Neuroradiologic Findings and Follow-up
AJNR 30:1971-1976, Uggetti,C.,et al, 2009

Gadolinium-Enhanced MR Cisternography to Evaluate Dural Leaks in Intracranial Hypotension Syndrome
AJNR 29:116-121, Albayram,S.,et al, 2008



Showing articles 0 to 50 of 282 Next >>